We have assembled an experienced team with strong scientific, clinical and commercial expertise.

InnoSIGN has years of experience in drug discovery, CDx development, commercial launch, and market access.

Meet the team

Eric Lindquist

Chief Executive Officer

Marianna Polonsky

VP of Commercial Strategy, BD & Market Access

Yvonne Wesseling-Rozendaal

Director of Data Science

Laurent Holtzer

VP of Engineering

Anne van Brussel

Application Scientist

Dianne van Strijp

Product Application Specialist

Gwen Sülter

Business Operations Manager

Board of Directors

Allan May

Chairman - Life Science Angels

Eric Lindquist

CEO InnoSIGN

Evan Castiglia

Thuja Capital

Mark Oldroyd

Independent Board Member

Paul Vernooij

Observer BOM

Benno Tieke

Observer Philips